| Schedule of Components of Income Tax Expense (Benefit) |
| | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2024 | | 2023 | | 2022 | | Current income tax expense (benefit) | | | | | | | U.S. federal | $ | 202 | | | $ | 240 | | | $ | 389 | | | U.S. state and local | 309 | | | 490 | | | 368 | | | Non-U.S. | 676 | | | 874 | | | 707 | | | Total current income tax expense (benefit) | 1,188 | | | 1,605 | | | 1,464 | | | Deferred income tax expense (benefit) | | | | | | | U.S. federal | 891 | | | (120) | | | 263 | | | U.S. state and local | 101 | | | (43) | | | 109 | | | Non-U.S. | 376 | | | (878) | | | 53 | | | Total deferred income tax expense (benefit) | 1,368 | | | (1,041) | | | 425 | | | Total income tax expense (benefit) | $ | 2,556 | | | $ | 563 | | | $ | 1,888 | |
|
| Schedule of Effective Income Tax Rate Reconciliation |
| | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2024 | | 2023 | | 2022 | | Income tax expense at U.S. federal statutory income tax rate | $ | 2,771 | | | $ | 2,084 | | | $ | 2,260 | | | State and local tax expense (benefit) | 323 | | | 348 | | | 388 | | | Non-U.S. income taxed at other than the U.S. federal statutory tax rate | 130 | | | 203 | | | 32 | | | U.S. tax impact on Non-U.S. income and activities | (49) | | | (62) | | | 5 | | | Change in valuation allowances | 46 | | | (1,061) | | | (392) | | | Change in tax laws | 9 | | | 25 | | | 78 | | | General business credits and manufacturing incentives | (906) | | | (966) | | | (829) | | | | | | | | | Settlements of prior year tax matters | — | | | 23 | | | — | | | Realization of basis differences in affiliates | (45) | | | — | | | 209 | | | Foreign currency remeasurement | 73 | | | (62) | | | 36 | | | Other adjustments | 204 | | | 31 | | | 102 | | | Total income tax expense (benefit) | $ | 2,556 | | | $ | 563 | | | $ | 1,888 | |
|
| Schedule of Deferred Tax Assets and Liabilities |
The following table summarizes the components of temporary differences and carryforwards that give rise to deferred tax assets and liabilities: | | | | | | | | | | | | | December 31, 2024 | | December 31, 2023 | | Deferred tax assets | | | | | Postretirement benefits other than pensions | $ | 1,024 | | | $ | 1,119 | | | Pension and other employee benefit plans | 1,421 | | | 1,522 | | | Warranties, dealer and customer allowances, claims and discounts | 4,215 | | | 3,684 | | | | | | | U.S. capitalized research expenditures | 10,111 | | | 9,879 | | | U.S. operating loss and tax credit carryforwards(a) | 6,582 | | | 6,033 | | | Non-U.S. operating loss and tax credit carryforwards(b) | 5,239 | | | 6,204 | | | Miscellaneous | 4,302 | | | 5,121 | | | Total deferred tax assets before valuation allowances | 32,894 | | | 33,562 | | | Less: valuation allowances | (6,529) | | | (6,979) | | | Total deferred tax assets | 26,365 | | | 26,583 | | | Deferred tax liabilities | | | | | Property, plant and equipment | 5,111 | | | 4,233 | | | Intangible assets | 635 | | | 699 | | | Total deferred tax liabilities | 5,746 | | | 4,932 | | | Net deferred tax assets | $ | 20,619 | | | $ | 21,651 | |
__________ (a)At December 31, 2024, U.S. operating loss deferred tax assets were $411 million, where $129 million can be carried forward indefinitely and $282 million will expire by 2042, if not utilized. At December 31, 2024, U.S. tax credit carryforwards were $6.2 billion, where $462 million can be carried forward indefinitely and $5.7 billion will expire by 2044, if not utilized. (b)At December 31, 2024, Non-U.S. operating loss deferred tax assets were $5.2 billion, where $4.8 billion can be carried forward indefinitely and $342 million will expire by 2044, if not utilized. At December 31, 2024, Non-U.S. tax credit carryforwards were $68 million, where $45 million can be carried forward indefinitely and $23 million will expire by 2043, if not utilized.
|